Answers are grounded in this paper and cite their sources.
Cross-sectional study reveals lung function impairment in diabetics, indicating potential complications with microangiopathy.
Diabetes mellitus is a systemic disease now recognized to affect the lungs through microangiopathy. This cross-sectional study assessed pulmonary function via spirometry in 132 diabetics and 132 controls. Diabetics showed significantly reduced FVC, FEV1 and PEFR, consistent with a restrictive pattern. Poor glycemic control correlated strongly with reduced lung function, while disease duration did not. Spirometry findings also correlated with albuminuria and retinopathy, supporting early screening utility.
No takes yet. Share an insight, caveat, or question.
Lokesh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: